MGMT and glioma: The expression of CpG Island Methylator Phenotype (CIMP) by d-2HG accounts for major gene expression changes [181] including the silencing of MGMT (O6-methylguanine DNA methyltransferase), which is a single most important determinant of glioma resistance to alkylating agents [182].